Mr X, 51 years of age, has a 30-year history of Crohn's disease. He has undergone 2 ileal resections in the past, the last one occurring 8 years ago. He has been receiving treatment with 6-mercaptopurine and adalimumab (Humira) since. He has lived in the northeast United States his entire life and traveled to Brazil, Uruguay, and Argentina 2 years ago.
Mr X developed fever and cough 2 weeks before presentation; chest radiograph showed a right lower lobe nodular density. Computed tomography of the chest confirmed a right lower lobe consolidation, as well as hilar and paratracheal lymphadenopathy. Positron emission tomography showed fluorodeoxyglucose-avid mediastinal and portocaval lymph nodes. Routine laboratory evaluation was normal except for an alanine aminotransferase level of 80 U/L and an erythrocyte sedimentation rate of 30 mm/h. QuantiFERON gold test was negative for history of exposure to Mycobacterium tuberculosis.
Which one of the following is the most likely diagnosis?
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Generic HIV Medicines: Boon or Bust?
- ACOG: Updated Recommendations for Influenza Vaccination During Pregnancy
- Pregnancy May Be Independently Associated With Prolonged Detection of Zika Virus RNA
- It Costs $2.2 Billion a Year to Treat Antibiotic Resistance
- An Effective Zika Vaccine May Eliminate Prenatal Infections
- Fingerstick Point-of-Care Test Allows for Single-Visit HCV Diagnoses
- Clostridium difficile Infection in the Intensive Care Setting
- Combating Medically Important Antibiotic Use in Food-Producing Animals
- Religious Exemptions vs Mandatory Vaccinations: An Expert Perspective
- 2018 Vaccination Schedule: Adults
- Possible Inhibitory Effect of HCV-Induced Steatogenesis by HBV
- Delayed Management of Severe Sepsis, Septic Shock Increases Mortality
- MenB Vaccine Gets Breakthrough Therapy Designation for Children Ages 1-9 Years
- CDC: Recommendations on the Use of Heplisav-B Published
- Non-Targeted HIV Testing in ED Acceptable to Patients